Computing and interpreting the Number Needed to Treat for Cardiovascular Outcomes Trials Perspective on GLP-1 RA and SGLT-2i therapies

Ludwig, L; Darmon, P; Guerci, B

Ludwig, L (corresponding author), Lorraine Univ, Endocrinol Diabetol & Nutr, CHRU Nancy, Brabois Hosp, F-54500 Vandoeuvre Les Nancy, France.

CARDIOVASCULAR DIABETOLOGY, 2020; 19 (1):

Abstract

The recent results of Cardiovascular Outcomes Trials (CVOTs) in type 2 diabetes have clearly established the cardiovascular (CV) safety or even the be......

Full Text Link